http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014534264-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 |
| filingDate | 2012-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2014534264-A |
| titleOfInvention | Heterocyclic compounds and uses thereof |
| abstract | Heterocyclic components that modulate PI3 kinase activity, pharmaceutical compositions containing the heterocyclic components, and methods of using these chemical components to treat diseases and conditions associated with PI3 kinase activity are described herein. Written in the book. In certain embodiments, the present invention provides a composition comprising a pharmaceutically acceptable excipient and one or more compounds prepared by the methods of the present invention. In some embodiments, the composition is in liquid, solid, semi-solid, gel, or aerosol form. [Selection figure] None |
| priorityDate | 2011-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 2187.